Category: Workers Comp

604 posts found

Novel Drug Approvals Supported by Fewer Studies

A study from PLOS One examined trends in drug approvals before and after implementation of new federal regulations for evidentiary standards.

This Month's Must Read

Coming Up Short: When Drug Shortages Become a Claims Problem

Shortages can increase costs, delay or alter treatment, increase complexity, and impact claims outcomes.

Legislation & Policy

Alaska Proposes Significant Pharmacy Reimbursement Changes

Impacted drugs include physician-dispensed and repackaged drugs, topicals, compounds, and OTC medications.

Psychedelic Developments

SAMHSA Recommends States Plan for Legal Implications of FDA-Approved Psychedelics

States are encouraged to plan now for the implications of potential psychedelic therapies, including Medicaid coverage obligations.

Healthe Developments

Hidden Comorbidities Complicate Workers Comp Claims

Business Insurance recaps an educational presentation held at WCI 2026, featuring Healthesystems VP of Clinical Services, Silvia Sacalis, PharmD, BS.

Medmonitor

Generic Drug Tariffs Announced for 2028

A 100% tariff will take effect August 1, 2028 for generic drugs imported into the U.S., followed by a 200% tariff in August 2029.

This Month's Must Read

6 Steps for More Effective Pharmacy Workflows

Effective pharmacy workflows pair greater efficiency with better health outcomes, reducing burden for claims professionals while increasing impact.

Industry Insights

WCRI Reports on Trends in Non-Price-Controlled Medical Services

The study focused on DME and professional services billed by nonhospital providers from January 1, 2019 through June 30, 2025.

image of New York state statue of liberty

Legislation & Policy

New York Broadens Pay Without Prejudice Rules

Effective January 1, 2027, payers may voluntarily cover medical treatment for up to one year while compensability determination is under review.

Psychedelic drugs and laboratory imagery

Psychedelic Developments

FDA Seeks Input on Potential Therapeutic Use of Psychedelic Drugs

A public hearing will be held on September 14th, with written comments accepted until October 5th.

Healthe Developments

In Person, In Print, and On Stage: Connect with Healthe at National Comp 2026!

Visit Healthe at Booth #415 to chat and pick up a copy of RxInformer magazine, or sit in on our panel discussion.

Medmonitor

FDA Approves Rextovy as OTC for Opioid Overdose

This approval marks the third OTC naloxone medication available for the treatment of opioid overdose.

This Month's Must Read

Deep Breath: Occupational Lung Disease and Pharmacy Management

These diseases are infrequent, but they can incur significant costs as they can be present for life, requiring ongoing monitoring, treatment, and medication.

Image of A doctor handing a patient medication

Legislation & Policy

State Activity Surrounding Physician Dispensing

Florida, Pennsylvania, and Michigan have recently made waves regarding physician dispensing.

Industry Insights

Migraine Drugs Are Now Number Three in Drug Spend in California

While migraine drugs make up less than 1% of prescriptions, they now make up 7.5% of drug spend, primarily driven by CGRP drugs.

1 2 3 4 5 … 37 38 39 40 41 Next